For over 15 years, GENEWIZ has accelerated life science research and discovery by providing researchers with high-quality, cost-effective, time-saving and innovative genomics solutions, including DNA sequencing, gene synthesis, molecular biology, next-generation sequencing, bioinformatics, and GxP/CLIA regulatory and clinical services. With a business model based on operational excellence and superior scientific support, GENEWIZ continues to attract customers and collaborators internationally from top academic, pharmaceutical and government agencies. GENEWIZ’s robust and rapidly evolving portfolio of genomics services and solutions includes commercial and proprietary next- generation sequencing (NGS) services.
State of Ownership
Former Head of Communities, Springer Nature
Sales Account Executive, Springer Nature
CEO & Co-Founder, Zapnito